A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young HIV patients achieve medication adherence and undetectable viral loads.

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Médecins Sans Frontières/Doctors without Borders (MSF) has started to roll out a new HIV prevention tool: a long-acting injectable pre-exposure prophylaxis. If we can get this drug to people at risk ...

The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Here, we show that accumulation of mutations in a drug-resistant HIV-1 protease (HIV-1 PR) variant, D30N/M36I/A71V, changes the fractional occupancy of the equilibrium conformational sampling ensemble ...

Currently, there are only limited FDA-approved drugs for GB, such as TMZ, Bevacizumab, CCNU, and BiCNU, highlighting the urgent need for new treatment options for GB. One of the most promising ...

Several studies have described improved outcomes for HIV-infected patients admitted to the intensive care unit (ICU) since the introduction of highly active antiretroviral therapy (HAART). A study was ...

For many, the fear of social exclusion or cultural taboos discouraged them from both testing for HIV and adhering to ART treatment: There are people who say that there is a traditional treatment ...

The administration has made policy changes that could impact HIV prevention and treatment efforts in Florida. South Florida has one of the highest HIV and AIDS infection rates in the country. The ...

Mounting evidence shows that people living with HIV-1 who have suppressed plasma HIV RNA on antiretroviral therapy do not transmit the virus ... Furthermore, concerns of drug-related adverse events, ...